Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early P 1 (1)

Trial Status

Recruiting1
Withdrawn1

Clinical Trials (2)

Showing 2 of 2 trials
NCT06807853Recruiting

A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS

NCT05119712Early Phase 1Withdrawn

Terbinafine Treatment of Axial Spondyloarthropathy

Showing all 2 trials

Research Network

Activity Timeline